EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanisms of action of the hexane extract of Hypericum brasiliense and its component uliginosin B against drug-resistant Staphylococcus aureus

Julia Chaves Scaffo iD, Sofia Trindade Mussi da Silva iD, Vitor Won-Held Rabelo iD, Leandro Stefano Sangenito iD, Lucas da Silva Abreu iD, Thaís P Mello iD, Leandro Rocha iD, André Luis Souza Dos Santos iD

ADMET and DMPK · 06.07.2026 · 14

DOI: 10.5599/admet.3333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ADMET and DMPK, online erschienen am 06.07.2026. Verfasst von Julia Chaves Scaffo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Applied Sciences for Health Products, Faculty of Pharmacy, Fluminense Federal University (UFF), Niterói, Brazil. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose: Microbial resistance is a major global health concern. Methicillin-resistant Staphylococcus aureus is particularly relevant due to its clinical significance, virulence and adaptability. In the search for novel antimicrobial agents, natural products emerged as important sources of bioactive molecules. Previous studies have identified Hypericum brasiliense as a plant with promising antibacterial properties. Experimental approach: We evaluated the susceptibility, mechanisms of action and toxicity of H. brasiliense hexane extract (heHb) and the isolated compounds uliginosin B (uliB), isouliginosin B and japonicin A against reference and drug-resistant S. aureus isolates. Key results: The heHb and uliB demonstrated strong antibacterial activity, exhibiting MICs of 3.125 to 6.25 µg mL-1 and MBCs of 6.25 to 12.5 µg mL-1. Isouliginosin B displayed moderate activity (MIC = 12.5 µg mL-1; MBC ≤50 µg mL-1), whereas japonicin A was inactive. Transmission and scanning electron microscopy revealed pronounced ultrastructural alterations in bacterial cells following exposure to either heHb or uliB, and these exposures induced oxidative stress without compromising plasma membrane integrity. Conversely, the antioxidant N-acetylcysteine partially restored bacterial growth. Docking analysis suggested that uliB might act as a competitive substrate for the NADH-2 enzyme and cytochrome bd oxidase. Moreover, heHb and uliB inhibited biofilm formation and disrupted mature biofilms. Cytotoxicity assays (Vero and HaCaT lineages) showed CC₅₀ >90 µg mL-1, and haemolysis occurred only at the highest concentrations. In vivo assessment using Galleria mellonella confirmed low toxicity. ADMET predictions indicated a favourable pharmacokinetic profile for uliB. Conclusion: UliB is likely a key bioactive compound of H. brasiliense, with promising therapeutic potential against S. aureus.

Schlagwörter

Stichwörter der Autor:innen

Galleria mellonellaNatural productsantimicrobial activitybacterial infectionsbiofilmtoxicity

Autor:innen und Institutionen

  • Graduate Program in Applied Sciences for Health Products, Faculty of Pharmacy, Fluminense Federal University (UFF), Niterói, Brazil.
  • Natural Products Technology Laboratory, Faculty of Pharmacy, Fluminense Federal University (UFF), Niterói, Brazil.
  • Laboratory of Advanced Studies of Emerging and Resistant Microorganisms, Paulo de Góes Microbiology Institute, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
  • Laboratory of Chemistry of Natural Products, Institute of Chemistry, Fluminense Federal University (UFF), Niterói, Brazil.
  • Department of Virology, Paulo de Góes Microbiology Institute, Center of Health Science, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
  • Collection of Environment and Health Fungi (CFAS), Fungal Section, Department of Microbiology, National Institute for Quality Control in Health (INCQS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.

ORCID-Profile: Julia Chaves Scaffo, Sofia Trindade Mussi da Silva, Vitor Won-Held Rabelo, Leandro Stefano Sangenito, Lucas da Silva Abreu, Thaís P Mello, Leandro Rocha, André Luis Souza Dos Santos

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Zitieren

APA

Scaffo, J. C., da Silva, S. T. M., Won-Held Rabelo, V., Sangenito, L. S., da Silva Abreu, L., Mello, T. P., Rocha, L., & Souza Dos Santos, A. L. (2026). Mechanisms of action of the hexane extract of Hypericum brasiliense and its component uliginosin B against drug-resistant Staphylococcus aureus. ADMET and DMPK, 14. https://doi.org/10.5599/admet.3333

Vancouver

Scaffo JC, da Silva STM, Won-Held Rabelo V, Sangenito LS, da Silva Abreu L, Mello TP, et al. Mechanisms of action of the hexane extract of Hypericum brasiliense and its component uliginosin B against drug-resistant Staphylococcus aureus. ADMET and DMPK. 2026;14. doi:10.5599/admet.3333

BibTeX
@article{Scaffo2026,
  author = {Scaffo, Julia Chaves and da Silva, Sofia Trindade Mussi and Won-Held Rabelo, Vitor and Sangenito, Leandro Stefano and da Silva Abreu, Lucas and Mello, Thaís P and Rocha, Leandro and Souza Dos Santos, André Luis},
  title = {Mechanisms of action of the hexane extract of Hypericum brasiliense and its component uliginosin B against drug-resistant Staphylococcus aureus},
  journal = {ADMET and DMPK},
  year = {2026},
  volume = {14},
  doi = {10.5599/admet.3333}
}
Kostenlos starten →